Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
b.value AG, officially known as b.value Deutsche Biotechnologie Beteiligungsaktiengesellschaft, is a venture capital firm founded in 2016 and headquartered in Dortmund, Germany. The firm specializes in investing in DeepTech startups, particularly in the biotechnology and advanced materials sectors. With a focus on sustainability, b.value AG aims to support innovative companies that contribute to a better future. The firm operates under a public limited company structure (Aktiengesellschaft) and functions as an evergreen holding vehicle.
As of now, b.value AG manages a portfolio of nine companies and has established itself as a key player in the European D-A-CH region, which includes Germany, Austria, and Switzerland. The firm is recognized for its commitment to identifying and nurturing early-stage companies that leverage groundbreaking technologies. Notably, b.value AG is affiliated with the IBB Netzwerk, a Berlin-based biotech investor network, enhancing its credibility within the German biotech ecosystem.
b.value AG primarily invests in pre-seed and seed-stage companies within the biotechnology sector, emphasizing areas such as precision fermentation, sustainable chemicals, food/feed, and life science methods. The firm also targets advanced materials, seeking opportunities that align with its sustainability goals. Their investment strategy is concentrated on the European D-A-CH region, where they acquire minority stakes in startups. This approach allows b.value AG to collaborate with co-investors, thereby minimizing risks and enhancing the potential for success among its portfolio companies.
The firm looks for exceptional founders who are developing groundbreaking technologies that can lead to sustainable solutions. b.value AG's investment thesis revolves around supporting startups that combine innovative ideas with strong operational capabilities. By focusing on minority stakes, the firm aims to foster collaborative environments that can drive growth and innovation in the DeepTech space.
b.value AG's portfolio consists of nine notable DeepTech startups, each contributing to advancements in biotechnology and materials science. Key companies include:
These companies exemplify b.value AG's commitment to supporting innovative solutions in biotechnology and advanced materials.
To pitch b.value AG, founders should submit their proposals through the firm’s website at bvalue.de. It is recommended to include a comprehensive pitch deck that outlines the business model, technology, and market potential. The firm prefers warm introductions but will consider direct submissions as well. Response times can vary, but founders should expect to hear back within a few weeks.
As of August 11, 2024, b.value AG made a notable investment in PL BioScience, focusing on human platelet lysate cell culture media for regenerative medicine. This investment aligns with their strategy of supporting innovative biotechnology startups.
In September 2025, b.value AG was recognized in Shizune's Top 50 Biotech VC funds in Germany rankings, highlighting its growing influence in the biotech investment space.
What are b.value AG's investment criteria?
b.value AG focuses on pre-seed and seed-stage investments in the biotechnology and advanced materials sectors. They seek startups that demonstrate innovative technologies and exceptional founding teams, particularly in areas like precision fermentation and sustainable chemicals.
How can I apply or pitch to b.value AG?
Founders can pitch their startups through the firm’s website at bvalue.de. It is advisable to include a detailed business plan and highlight the innovative aspects of the technology being developed.
What makes b.value AG different from other investors?
b.value AG emphasizes a collaborative investment approach, acquiring minority stakes and partnering with co-investors to minimize risks. This strategy allows them to provide more comprehensive support to their portfolio companies.
What is the geographic scope of b.value AG's investments?
The firm primarily targets the European D-A-CH region, which includes Germany, Austria, and Switzerland, focusing on startups that operate within this geographic area.
What kind of post-investment involvement does b.value AG have?
b.value AG actively engages with its portfolio companies, leveraging its technology expertise and operational experience to support growth and innovation. This involvement often includes strategic guidance and operational support.
What is the typical check size for investments made by b.value AG?
While specific check sizes are not disclosed, b.value AG focuses on pre-seed and seed-stage investments, which typically range from €100,000 to €1 million, depending on the startup's needs and potential.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.